Market Overview:
The global cell therapy market size reached US$ 9.17 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 27.05 Billion by 2027, exhibiting a growth rate (CAGR) of 18.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Cell therapy (CT) is the transplantation of human cells to replace or repair damaged tissues and cells. It comprises hematopoietic stem cells (HSC), skeletal muscle and mesenchymal stem cells, lymphocytes, and dendritic and pancreatic islet cells. It improves the immune system of the body to fight cancer cells. Apart from this, cell therapy assists in treating various conditions, such as autoimmune and infectious diseases, urinary problems, damaged cartilage in joints, spinal cord injuries, a weakened immune system, and neurological disorders. At present, it is used to manufacture regenerative medicines for developing and applying new treatments to heal tissues and organs and restore functions lost due to aging, disease, and damage.
Cell Therapy Market Trends:
At present, there is a rise in the prevalence of various diseases, such as cancer and cardiac abnormalities, across the globe. This, along with the growing number of clinical studies for cell-based therapies, represents one of the key factors driving the market. Besides this, governing agencies of several countries are promoting clinical trials around the world, which is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce skin rejuvenation and tendon regeneration therapies. They are also focusing on developing direct cell reprogramming to replace lost neuronal tissues due to neurodegeneration or neurotrauma. Moreover, there is an increase in the development of advanced genomic therapy techniques to treat various diseases, such as cystic fibrosis, heart disease, diabetes, hemophilia, and acquired immune deficiency syndrome (AIDS). This, coupled with the burgeoning healthcare industry, is propelling the growth of the market. Apart from this, the rising demand for regenerative medicines to replace tissue or organs damaged by diseases, traumas, or congenital issues is bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell therapy market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on cell type, therapy type, therapeutic area and end user.
Breakup by Cell Type:
- Stem Cell
- Bone Marrow
- Blood
- Umbilical Cord-Derived
- Adipose-Derived Stem Cell
- Others
- Non-stem Cell
Breakup by Therapy Type:
Breakup by Therapeutic Area:
- Malignancies
- Musculoskeletal Disorders
- Autoimmune Disorders
- Dermatology
- Others
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AlloSource, Anterogen Co. Ltd., Cells for Cells, Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals, Kolon TissueGene Inc., MEDIPOST, Mesoblast Limited, NuVasive, Stemedica Cell Technologies Inc., Stempeutics Research Pvt. Ltd and Vericel Corporation.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Cell Type, Therapy Type, Therapeutic Area, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
AlloSource, Anterogen Co. Ltd., Cells for Cells, Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals, Kolon TissueGene Inc., MEDIPOST, Mesoblast Limited, NuVasive, Stemedica Cell Technologies Inc., Stempeutics Research Pvt. Ltd and Vericel Corporation. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global cell therapy market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global cell therapy market?
- What are the key regional markets?
- What is the breakup of the market based on the cell type?
- What is the breakup of the market based on the therapy type?
- What is the breakup of the market based on the therapeutic area?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cell therapy market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cell Therapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Cell Type
6.1 Stem Cell
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Bone Marrow
6.1.2.2 Blood
6.1.2.3 Umbilical Cord-Derived
6.1.2.4 Adipose-Derived Stem Cell
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Non-stem Cell
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapy Type
7.1 Autologous
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Allogeneic
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Therapeutic Area
8.1 Malignancies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Musculoskeletal Disorders
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Autoimmune Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Dermatology
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AlloSource
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.2 Anterogen Co. Ltd.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.3 Cells for Cells
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Holostem Terapie Avanzate S.r.l.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 JCR Pharmaceuticals
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Kolon TissueGene Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 MEDIPOST
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Mesoblast Limited
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 NuVasive
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Stemedica Cell Technologies Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Stempeutics Research Pvt. Ltd
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Vericel Corporation
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Cell Therapy Market: Major Drivers and Challenges
Figure 2: Global: Cell Therapy Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cell Therapy Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Cell Therapy Market: Breakup by Cell Type (in %), 2021
Figure 5: Global: Cell Therapy Market: Breakup by Therapy Type (in %), 2021
Figure 6: Global: Cell Therapy Market: Breakup by Therapeutic Area (in %), 2021
Figure 7: Global: Cell Therapy Market: Breakup by End User (in %), 2021
Figure 8: Global: Cell Therapy Market: Breakup by Region (in %), 2021
Figure 9: Global: Cell Therapy (Stem Cell) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Cell Therapy (Stem Cell) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Cell Therapy (Non-stem Cell) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Cell Therapy (Non-stem Cell) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Cell Therapy (Autologous) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Cell Therapy (Autologous) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Cell Therapy (Allogeneic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Cell Therapy (Allogeneic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Cell Therapy (Malignancies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Cell Therapy (Malignancies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Cell Therapy (Musculoskeletal Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Cell Therapy (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Cell Therapy (Autoimmune Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Cell Therapy (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Cell Therapy (Dermatology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Cell Therapy (Dermatology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Cell Therapy (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Cell Therapy (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Cell Therapy (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Cell Therapy (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Cell Therapy (Academic and Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Cell Therapy (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Cell Therapy Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Cell Therapy Industry: SWOT Analysis
Figure 81: Global: Cell Therapy Industry: Value Chain Analysis
Figure 82: Global: Cell Therapy Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Cell Therapy Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cell Therapy Market Forecast: Breakup by Cell Type (in Million US$), 2022-2027
Table 3: Global: Cell Therapy Market Forecast: Breakup by Therapy Type (in Million US$), 2022-2027
Table 4: Global: Cell Therapy Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
Table 5: Global: Cell Therapy Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Cell Therapy Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Cell Therapy Market: Competitive Structure
Table 8: Global: Cell Therapy Market: Key Players